• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们能否在临床高风险状态之外预测精神病?非精神病性精神障碍风险综合征的系统综述。

Can We Predict Psychosis Outside the Clinical High-Risk State? A Systematic Review of Non-Psychotic Risk Syndromes for Mental Disorders.

机构信息

Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea.

Department of Brain and Cognitive Sciences, Seoul National University College of Natural Sciences, Seoul, Republic of Korea.

出版信息

Schizophr Bull. 2018 Feb 15;44(2):276-285. doi: 10.1093/schbul/sbx173.

DOI:10.1093/schbul/sbx173
PMID:29438561
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5814842/
Abstract

Recent evidence has suggested that psychosis could develop not only in people at clinical high risk for psychosis (CHR-P) but also in those with clinical risk syndromes for emergent nonpsychotic mental disorders. The proportion of people with these clinical risk syndromes who will develop psychosis rather than to other nonpsychotic mental disorders is undetermined. Electronic databases were searched for studies reporting on clinical risk syndromes for the development of emergent nonpsychotic mental disorders. Incidence of emerging psychotic and nonpsychotic mental disorders defined on the ICD or DSM. Of a total of 9 studies relating to 3006 nonpsychotic at-risk individuals were included. Within prospective studies (n = 4, sample = 1051), the pooled incidence of new psychotic disorders across these clinical risk syndromes was of 12.9 per 1000 person-years (95% CI: 4.3 to 38.6) and that of nonpsychotic disorders (n = 3, sample = 538) was of 43.5 per 1000 person-years (95% CI: 30.9 to 61.3). Psychotic disorders may emerge outside the CHR-P paradigm, from clinical risk syndromes for incident nonpsychotic disorders, albeit at lower rates than in the CHR-P group. The clinical risk syndromes for emerging nonpsychotic disorders may exhibit a pluripotential risk of developing several types of mental disorders compared with CHR-P. If substantiated by future research, the current findings suggest that it may be useful to move beyond the current strategy of identifying individuals meeting CHR-P criteria only.

摘要

最近的证据表明,精神病不仅可能发生在有精神病临床高风险(CHR-P)的人群中,也可能发生在有临床风险综合征的急性非精神病性精神障碍人群中。这些有临床风险综合征的人群中,有多少人会发展为精神病,而不是其他非精神病性精神障碍,目前还不确定。电子数据库中检索了报告关于急性非精神病性精神障碍发展的临床风险综合征的研究。ICD 或 DSM 定义的新发精神病和非精神病性精神障碍的发病率。共有 9 项涉及 3006 名非精神病高危个体的研究被纳入。在前瞻性研究(n=4,样本=1051)中,这些临床风险综合征新发精神病障碍的累积发病率为每 1000 人年 12.9 例(95%CI:4.3 至 38.6),非精神病障碍(n=3,样本=538)的发病率为每 1000 人年 43.5 例(95%CI:30.9 至 61.3)。精神病可能发生在 CHR-P 范式之外,源于急性非精神病性障碍的临床风险综合征,尽管发病率低于 CHR-P 组。与 CHR-P 相比,新发非精神病性障碍的临床风险综合征可能表现出多种精神障碍的多潜能风险。如果未来的研究得到证实,目前的发现表明,超越目前仅识别符合 CHR-P 标准的个体的策略可能是有用的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77dd/5814842/7815718640bb/sbx17302.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77dd/5814842/5ca075eb02bf/sbx17301.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77dd/5814842/7815718640bb/sbx17302.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77dd/5814842/5ca075eb02bf/sbx17301.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77dd/5814842/7815718640bb/sbx17302.jpg

相似文献

1
Can We Predict Psychosis Outside the Clinical High-Risk State? A Systematic Review of Non-Psychotic Risk Syndromes for Mental Disorders.我们能否在临床高风险状态之外预测精神病?非精神病性精神障碍风险综合征的系统综述。
Schizophr Bull. 2018 Feb 15;44(2):276-285. doi: 10.1093/schbul/sbx173.
2
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
3
Early intervention for psychosis.精神病的早期干预
Cochrane Database Syst Rev. 2006 Oct 18(4):CD004718. doi: 10.1002/14651858.CD004718.pub2.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Cognitive behavioural therapy (group) for schizophrenia.认知行为疗法(团体)治疗精神分裂症。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD009608. doi: 10.1002/14651858.CD009608.pub2.
6
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
8
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
9
Psychological and/or educational interventions for the prevention of depression in children and adolescents.预防儿童和青少年抑郁症的心理和/或教育干预措施。
Cochrane Database Syst Rev. 2004(1):CD003380. doi: 10.1002/14651858.CD003380.pub2.
10
Behavioural and cognitive behavioural therapy for obsessive compulsive disorder (OCD) in individuals with autism spectrum disorder (ASD).针对自闭症谱系障碍(ASD)个体的强迫症(OCD)的行为和认知行为疗法。
Cochrane Database Syst Rev. 2021 Sep 3;9(9):CD013173. doi: 10.1002/14651858.CD013173.pub2.

引用本文的文献

1
Multimodal Prediction of Psychosis in the Prospective MoBa Birth Cohort.前瞻性母婴队列研究中精神病的多模态预测
Res Sq. 2025 Jun 20:rs.3.rs-6783339. doi: 10.21203/rs.3.rs-6783339/v1.
2
Obstacles to Seeking Help: Perceived Barriers and Stigma Towards Mental Health Treatment in College Students at Elevated Risk for Psychosis.寻求帮助的障碍:处于精神病高风险的大学生对心理健康治疗的感知障碍和污名化
Early Interv Psychiatry. 2025 Apr;19(4):e70034. doi: 10.1111/eip.70034.
3
Development and temporal validation of a clinical prediction model of transition to psychosis in individuals at ultra-high risk in the UHR 1000+ cohort.

本文引用的文献

1
Lack of Diagnostic Pluripotentiality in Patients at Clinical High Risk for Psychosis: Specificity of Comorbidity Persistence and Search for Pluripotential Subgroups.临床精神病高危患者缺乏诊断多能性:共病持续存在的特异性及多潜能亚组的寻找。
Schizophr Bull. 2018 Feb 15;44(2):254-263. doi: 10.1093/schbul/sbx138.
2
Why transition risk to psychosis is not declining at the OASIS ultra high risk service: The hidden role of stable pretest risk enrichment.为什么 OASIS 超高风险服务中向精神病的转变风险没有降低:稳定的前期风险富集的隐藏作用。
Schizophr Res. 2018 Feb;192:385-390. doi: 10.1016/j.schres.2017.06.015. Epub 2017 Jul 20.
3
UHR 1000+队列中超高风险个体向精神病转变的临床预测模型的开发与时间验证。
World Psychiatry. 2024 Oct;23(3):400-410. doi: 10.1002/wps.21240.
4
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis.加速药物研发合作组织精神分裂症项目(AMP® SCZ):精神分裂症前驱症状全球最大前瞻性队列研究的基本原理和研究设计。
Schizophr Bull. 2024 Apr 30;50(3):496-512. doi: 10.1093/schbul/sbae011.
5
Psychosis superspectrum I: Nosology, etiology, and lifespan development.精神病超谱系I:疾病分类学、病因学和终生发展
Mol Psychiatry. 2024 Apr;29(4):1005-1019. doi: 10.1038/s41380-023-02388-2. Epub 2024 Jan 10.
6
Improving screening methods for psychosis in an adolescent help-seeking population using the Child Behavior Checklist (CBCL) and the Youth Self Report (YSR) versus the Prodromal Questionnaire -16 items version (PQ-16).使用儿童行为量表(CBCL)、青少年自评量表(YSR)与前驱症状问卷16项版本(PQ - 16)改进青少年求助人群中精神病的筛查方法。
Child Adolesc Psychiatry Ment Health. 2022 Mar 31;16(1):25. doi: 10.1186/s13034-022-00459-w.
7
Neuropsychological Performance Among Individuals at Clinical High-Risk for Psychosis vs Putatively Low-Risk Peers With Other Psychopathology: A Systematic Review and Meta-Analysis.临床精神病高危个体与其他精神病性障碍低危个体的神经心理学表现:系统评价和荟萃分析。
Schizophr Bull. 2022 Sep 1;48(5):999-1010. doi: 10.1093/schbul/sbac031.
8
MicroRNAs in the Onset of Schizophrenia.精神分裂症发病中的 microRNAs。
Cells. 2021 Oct 6;10(10):2679. doi: 10.3390/cells10102679.
9
Toward Generalizable and Transdiagnostic Tools for Psychosis Prediction: An Independent Validation and Improvement of the NAPLS-2 Risk Calculator in the Multisite PRONIA Cohort.迈向通用和跨诊断精神分裂症预测工具:NAPLS-2 风险计算器在多中心 PRONIA 队列中的独立验证和改进。
Biol Psychiatry. 2021 Nov 1;90(9):632-642. doi: 10.1016/j.biopsych.2021.06.023. Epub 2021 Jul 6.
10
Psychiatric risk and resilience: Plasticity genes and positive mental health.精神疾病风险与恢复力:可塑性基因与积极心理健康
Brain Behav. 2021 Jun;11(6):e02137. doi: 10.1002/brb3.2137. Epub 2021 May 1.
Extending the Benefits of Indicated Prevention to Improve Outcomes of First-Episode Psychosis.
扩展针对性预防的益处以改善首发精神病的治疗结果。
JAMA Psychiatry. 2017 Jul 1;74(7):667-668. doi: 10.1001/jamapsychiatry.2017.1009.
4
Diagnostic and Prognostic Significance of DSM-5 Attenuated Psychosis Syndrome in Services for Individuals at Ultra High Risk for Psychosis.DSM-5 轻度精神病综合征在超高风险精神病患者服务中的诊断和预后意义。
Schizophr Bull. 2018 Feb 15;44(2):264-275. doi: 10.1093/schbul/sbx055.
5
Why ultra high risk criteria for psychosis prediction do not work well outside clinical samples and what to do about it.为何用于精神病预测的超高风险标准在临床样本之外效果不佳以及如何应对这一问题。
World Psychiatry. 2017 Jun;16(2):212-213. doi: 10.1002/wps.20405.
6
Development and Validation of a Clinically Based Risk Calculator for the Transdiagnostic Prediction of Psychosis.一种基于临床的精神病跨诊断预测风险计算器的开发与验证
JAMA Psychiatry. 2017 May 1;74(5):493-500. doi: 10.1001/jamapsychiatry.2017.0284.
7
Long-term validity of the At Risk Mental State (ARMS) for predicting psychotic and non-psychotic mental disorders.高危精神状态(ARMS)预测精神病性和非精神病性精神障碍的长期有效性。
Eur Psychiatry. 2017 May;42:49-54. doi: 10.1016/j.eurpsy.2016.11.010. Epub 2016 Dec 6.
8
Prodrome or risk syndrome: what's in a name?前驱症状还是风险综合征:名称有何意义?
Int J Bipolar Disord. 2017 Dec;5(1):7. doi: 10.1186/s40345-017-0077-5. Epub 2017 Apr 10.
9
Course of clinical high-risk states for psychosis beyond conversion.精神病转化后临床高危状态的进程。
Eur Arch Psychiatry Clin Neurosci. 2018 Feb;268(1):39-48. doi: 10.1007/s00406-016-0764-8. Epub 2017 Jan 4.
10
The Clinical High-Risk State for Psychosis (CHR-P), Version II.精神病临床高危状态(CHR-P),第二版
Schizophr Bull. 2017 Jan;43(1):44-47. doi: 10.1093/schbul/sbw158.